Ensuring reproducible analysis results in SARS-CoV-2 research

Ensuring reproducible analysis results in SARS-CoV-2 research

About the webinar

Since the emergence of the COVID-19 pandemic, extensive studies have continued to explore the disease pathogenesis, as well as acquired and induced immunity against the infection. With the recent development and dissemination of COVID-19 vaccinations, cellular analysis of  T and B cells has become crucial not only for patient monitoring, but also in evaluating the efficiency of immunization of candidate and established vaccines. 

Working with these rare cells can prove challenging to researchers: critically low cell frequencies, inflammatory environments, unspecific labeling, and high levels of background noise often hamper reliable analysis. In this webinar, we will introduce solutions for the efficient and reproducible analysis of these cell types in 
SARS-CoV-2 research.  

Learning objectives:

  • Importance of cellular analysis in SARS-CoV-2 research 
  • Precise analysis of SARS-CoV-2–reactive T cells in PBMC or whole blood samples 
  • Detection, phenotyping, and sorting of SARS-CoV-2–specific B cells


Urmi Roy

2018 – present: Product Manager for the flow cytometry reagent portfolio at Miltenyi Biotec 
2014 – 2018 PhD in Immunology at TU Braunschweig, where she specialized in mucosal immunology/gut microbiota

Lorenz Fülle

2020 – present: Global Product Manager for antigen- and virus-specific T cells 
2013 – 2020: PhD in Immunology and Post-doctoral Fellow at the Department of Immunology & Environment, University of Bonn, Germany

Jessica Mrugala

2021 – present: Junior Global Product Manager for the MACSprep Portfolio and supporting the SARS-CoV-2 T cell project at Miltenyi Biotec  
2015-2021: PhD and Postdoc in Diabetes Research at the German Diabetes Center, Düsseldorf 

Cristina Conforti Andreoni

2018 –present: Group Leader, Marketing Immunology, Miltenyi Biotec 
2015 – 2018: Global Product Manager, Myeloid Cell Products, Miltenyi Biotec 
2013 – 2015 Global Product Manager, Cell Culture, Miltenyi Biotec 
2011 – 2012 Scientific Officer, Ayoxxa 
2001 – 2011: BSc and MSc in Medical Biotechnology, and PhD on dendritic cells and danger signals, University  of Milan-Bicocca / A-STAR, SIgN, Singapore; Post-doctoral Fellow, A-STAR, SIgN, Singapore  on dendritic cells and Th17 cells in inflammation

Watch the complete webinar for free

Your Miltenyi University benefits

Access online courses anytime, anywhere.

Become an expert in standard and innovative applications.

Acquire broad expertise and a comprehensive skill set.

Let us know your thoughts!

You did not find the course you are looking for? 
Do you have questions or comments? 
Drop us an e-mail!

Seems like you are coming from USA!
Do you want to visit our website in your country?